Victory Capital Management Inc Haemonetics Corp Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

A detailed history of Victory Capital Management Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Victory Capital Management Inc holds 278,886 shares of HAE stock, worth $22.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
278,886
Previous 277,169 0.62%
Holding current value
$22.9 Million
Previous $22.9 Million 2.25%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
$72.45 - $91.58 $124,396 - $157,242
1,717 Added 0.62%
278,886 $22.4 Million
Q2 2024

Aug 05, 2024
BUY
$81.24 - $97.37 $7.07 Million - $8.48 Million
87,042 Added 45.78%
277,169 $22.9 Million
Q1 2024

May 03, 2024
SELL
$71.24 - $85.35 $1.23 Million - $1.47 Million
-17,214 Reduced 8.3%
190,127 $16.2 Million
Q4 2023

Feb 05, 2024
SELL
$80.59 - $92.61 $12.1 Million - $13.9 Million
-149,962 Reduced 41.97%
207,341 $17.7 Million
Q3 2023

Nov 06, 2023
BUY
$82.56 - $93.49 $9.83 Million - $11.1 Million
119,072 Added 49.98%
357,303 $32 Million
Q2 2023

Jul 27, 2023
SELL
$80.84 - $89.45 $240,094 - $265,666
-2,970 Reduced 1.23%
238,231 $20.3 Million
Q1 2023

May 02, 2023
SELL
$72.75 - $90.6 $322,064 - $401,086
-4,427 Reduced 1.8%
241,201 $20 Million
Q4 2022

Feb 10, 2023
BUY
$73.85 - $86.14 $26,512 - $30,924
359 Added 0.15%
245,628 $19.3 Million
Q4 2022

Feb 09, 2023
SELL
$73.85 - $86.14 $4.14 Million - $4.82 Million
-56,006 Reduced 18.59%
245,269 $19.3 Million
Q3 2022

Nov 02, 2022
SELL
$63.3 - $78.66 $4.81 Million - $5.98 Million
-75,977 Reduced 20.14%
301,275 $22.3 Million
Q2 2022

Aug 01, 2022
BUY
$49.27 - $66.08 $16.5 Million - $22.2 Million
335,736 Added 808.69%
377,252 $24.6 Million
Q1 2022

May 04, 2022
BUY
$43.77 - $63.22 $1.53 Million - $2.21 Million
34,898 Added 527.32%
41,516 $2.43 Million
Q4 2021

Feb 07, 2022
BUY
$49.55 - $74.59 $5,500 - $8,279
111 Added 1.71%
6,618 $351,000
Q3 2021

Nov 02, 2021
BUY
$57.6 - $70.59 $4,780 - $5,858
83 Added 1.29%
6,507 $459,000
Q2 2021

Aug 03, 2021
SELL
$51.81 - $118.56 $13,677 - $31,299
-264 Reduced 3.95%
6,424 $428,000
Q1 2021

May 04, 2021
SELL
$111.01 - $139.48 $31,859 - $40,030
-287 Reduced 4.11%
6,688 $742,000
Q4 2020

Feb 01, 2021
SELL
$88.75 - $119.95 $2.5 Million - $3.38 Million
-28,179 Reduced 80.16%
6,975 $828,000
Q3 2020

Nov 09, 2020
SELL
$75.65 - $93.58 $32,680 - $40,426
-432 Reduced 1.21%
35,154 $3.07 Million
Q2 2020

Aug 07, 2020
BUY
$84.96 - $118.91 $363,458 - $508,696
4,278 Added 13.66%
35,586 $3.19 Million
Q1 2020

May 04, 2020
BUY
$74.34 - $121.82 $1.4 Million - $2.29 Million
18,780 Added 149.9%
31,308 $3.12 Million
Q4 2019

Feb 06, 2020
BUY
$114.37 - $129.46 $13,381 - $15,146
117 Added 0.94%
12,528 $1.44 Million
Q4 2019

Feb 04, 2020
BUY
$114.37 - $129.46 $369,872 - $418,673
3,234 Added 35.24%
12,411 $1.33 Million
Q3 2019

Nov 12, 2019
BUY
$117.16 - $138.52 $1.08 Million - $1.27 Million
9,177 New
9,177 $1.16 Million
Q3 2018

Nov 01, 2018
SELL
$89.96 - $114.58 $28.8 Million - $36.6 Million
-319,653 Closed
0 $0
Q2 2018

Aug 02, 2018
SELL
$71.53 - $95.75 $85 Million - $114 Million
-1,188,241 Reduced 78.8%
319,653 $28.7 Million
Q1 2018

May 04, 2018
SELL
$60.72 - $74.41 $55.9 Million - $68.5 Million
-920,342 Reduced 37.9%
1,507,894 $110 Million
Q4 2017

Feb 01, 2018
BUY
$44.96 - $58.99 $616,401 - $808,752
13,710 Added 0.57%
2,428,236 $141 Million
Q3 2017

Oct 27, 2017
BUY
$40.38 - $44.87 $15.4 Million - $17.1 Million
381,012 Added 18.74%
2,414,526 $108 Million
Q2 2017

Aug 07, 2017
BUY
N/A
2,033,514
2,033,514 $80.3 Million

Others Institutions Holding HAE

# of Institutions
333
Shares Held
54M
Call Options Held
689K
Put Options Held
345K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.21B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email